Jiangsu Zecen Biotech Co., Ltd. (hereinafter referred to Zecen Biotech), is an in vitro enterprise who is mainly specialized in providing total solution of chemiluminescence immunoassay by developing, manufacturing and marketing the CLIA instruments and reagents. Founded in 2o11, Zecen Biotech won the reputation as a national high-tech enterprise in 2014. The independently researched and developed instrument and reagent kits have been audited by TUV and got the CE mark in 2017, which means that Zecen Biotech already got the ticket to the competition with international big players.
Zecen Biotech insists on continuous innovation, promote the development of precision medicine, who is the only one to own full intellectual property for chemiluminescence immunoassay based on the magnetic particles. Besides, a number of invention patents, registered trademarks and medical device registration certificates for Class III and Class II products have been acquired. Zecen Biotech not only has dominant CLIA products, but also has high-valued clinical chemistry products. The research and development centers and production base have been set up in Beijing, Shandong, Jiangsu and etc.
Zecen Biotech has already cooperated with first or second class hospitals in domestic market an built friendly business relationship with customers in middle-south Asia, South America, east and south Europe countries in the international market.
With the mission of “Technology is to change life”, Zecen Biotech strives to be the most respectable Chinese brand in healthcare field.